Publications by authors named "Imene Haddad"

Claim this Profile
A
A plain language summary of LocoMMotion - an observational study of treatments used for pretreated multiple myeloma.
Michel Delforge, Eilidh Duncan, María-Victoria Mateos, Imène Haddad, Wafae Iraki

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent Studies.
Philippe Moreau, María-Victoria Mateos, Hartmut Goldschmidt, Maria Esther Gonzalez Garcia, Britta Besemer, Imène Haddad

Clin Lymphoma Myeloma Leuk· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma - 2-year follow-up (final analysis).
María-Victoria Mateos, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Imène Haddad

Leukemia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study.
Maria-Victoria Mateos, Katja Weisel, Joris Diels, Alberto Arribas, Maria Tamayo, Imène Haddad

Clin Lymphoma Myeloma Leuk· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
Hermann Einsele, Philippe Moreau, Nizar Bahlis, Manisha Bhutani, Laure Vincent, Imene Haddad

Adv Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer across four countries in the Middle East: a multi-centre, observational, retrospective and prognostic study.
Fadi El-Karak, Ali Shamseddine, Ayman Omar, Imene Haddad, Mahmoud Abdelgawad

Ecancermedicalscience· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
Philippe Moreau, María-Victoria Mateos, Maria Esther Gonzalez Garcia, Hermann Einsele, Valerio De Stefano, Imène Haddad

Adv Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis